Brief: Xlife Sciences: Pleasing Progress In First Half Of 2022
28/09/2022 06:03
Sept 28 (Reuters) - Xlife Sciences AG XLS.S :
* XLIFE SCIENCES WITH PLEASING PROGRESS IN FIRST HALF OF
2022
Source text for Eikon: ID:nEQ21gD5Qa
Further company coverage: XLS.S
(Reporting by Paul Carrel)
((paul.carrel@thomsonreuters.com;))
Recent news on Xlife Sciences AG
See all newsSwiss stocks - Factors to watch on July 17
Brief: Xlife Sciences AG Says Transaction With Veraxa, Offers Potential For A Significant Partial Exit Of Company's Investment
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal (updated)
Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal
Brief: Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.